GB1168105A - Quinoline Derivatives - Google Patents

Quinoline Derivatives

Info

Publication number
GB1168105A
GB1168105A GB38463/67A GB3846367A GB1168105A GB 1168105 A GB1168105 A GB 1168105A GB 38463/67 A GB38463/67 A GB 38463/67A GB 3846367 A GB3846367 A GB 3846367A GB 1168105 A GB1168105 A GB 1168105A
Authority
GB
United Kingdom
Prior art keywords
alkyl
compositions
veterinary
pharmaceutical compositions
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB38463/67A
Inventor
William Glynne Moss Jones
Margaret Edna Rider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB38463/67A priority Critical patent/GB1168105A/en
Priority to FR1590673D priority patent/FR1590673A/fr
Priority to NL6811887A priority patent/NL6811887A/xx
Priority to DE19681795194 priority patent/DE1795194A1/en
Priority to FR174511A priority patent/FR7975M/fr
Publication of GB1168105A publication Critical patent/GB1168105A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1,168,105. Antiparasitic compositions. IMPERIAL CHEMICAL INDUSTRIES Ltd. 16 July, 1968 [21 Aug., 1967], No. 38463/67. Heading A5B. [Also in Division C2] Veterinary and pharmaceutical compositions contain as active ingredient a compound of formula having anti-coccidial or antimalarial activity, wherein R<SP>1</SP> is alkyl, R<SP>2</SP> and R<SP>3</SP> are each H or alkyl, and R<SP>4</SP> is alkyl (at least C 6 when both R<SP>2</SP> and R<SP>3</SP> are alkyl), aryloxyalkyl or aralkyl, the aryl nucleus of which may be halogen-or alkyl-substituted. The veterinary compositions may be in the form of concentrated food premixes or medicated foodstuffs, and may contain known coccidiostats, anthelmintics, growth promoters, antibacterials or tranquilisers. The pharmaceutical compositions may be in the form of tablets, capsules, or (possibly sterile) aqueous or oily suspensions or emulsions, and preferably are injectable compositions providing a depot from which the quinoline derivative is relaxed over an extended period; also present may be other antimalarial agents such as proguanil, the derived dihydro-s-triazine, pyrimethamine, p,p<SP>1</SP>-diaminodiphenyl sulphone, chloroquine or primaquine.
GB38463/67A 1967-08-21 1967-08-21 Quinoline Derivatives Expired GB1168105A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB38463/67A GB1168105A (en) 1967-08-21 1967-08-21 Quinoline Derivatives
FR1590673D FR1590673A (en) 1967-08-21 1968-08-21
NL6811887A NL6811887A (en) 1967-08-21 1968-08-21
DE19681795194 DE1795194A1 (en) 1967-08-21 1968-08-21 Quinoline derivatives and processes for their preparation
FR174511A FR7975M (en) 1967-08-21 1968-11-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38463/67A GB1168105A (en) 1967-08-21 1967-08-21 Quinoline Derivatives

Publications (1)

Publication Number Publication Date
GB1168105A true GB1168105A (en) 1969-10-22

Family

ID=10403617

Family Applications (1)

Application Number Title Priority Date Filing Date
GB38463/67A Expired GB1168105A (en) 1967-08-21 1967-08-21 Quinoline Derivatives

Country Status (4)

Country Link
DE (1) DE1795194A1 (en)
FR (2) FR1590673A (en)
GB (1) GB1168105A (en)
NL (1) NL6811887A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3231455A1 (en) 1981-08-26 1983-03-10 L'Oreal, 75008 Paris METHOD FOR THE PRODUCTION OF NITROANILINES, THE USE THEREOF AND COLORING AGENTS THAT CONTAIN IT, AND NEW NITROANILINE
EP1984325A2 (en) * 2006-02-03 2008-10-29 The Ohio State University Research Foundation Sulfonanilide analogs as selective aromatase modulators

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2512016A1 (en) * 1981-08-26 1983-03-04 Oreal Nitroaniline deriv. prepn. from 3,4-methylene di:oxy:nitrobenzene - and amine or ammonia, used in tinctorial compsns. give weather- and wash fast yellow shades

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3231455A1 (en) 1981-08-26 1983-03-10 L'Oreal, 75008 Paris METHOD FOR THE PRODUCTION OF NITROANILINES, THE USE THEREOF AND COLORING AGENTS THAT CONTAIN IT, AND NEW NITROANILINE
DE3249986C2 (en) * 1981-08-26 1992-03-19 L'oreal, Paris, Fr
EP1984325A2 (en) * 2006-02-03 2008-10-29 The Ohio State University Research Foundation Sulfonanilide analogs as selective aromatase modulators
EP1984325A4 (en) * 2006-02-03 2011-08-10 Univ Ohio State Res Found Sulfonanilide analogs as selective aromatase modulators

Also Published As

Publication number Publication date
FR1590673A (en) 1970-04-20
FR7975M (en) 1970-06-01
NL6811887A (en) 1969-02-25
DE1795194A1 (en) 1971-12-30

Similar Documents

Publication Publication Date Title
GB1214012A (en) Phenylethanolamines
GB1335493A (en) 1a-beta-d arabinofuranosyl cytosine derivatives and process for making same
GB1168105A (en) Quinoline Derivatives
GB1461032A (en) Erthromycylamine derivatives
GB1462036A (en) Aminoindane derivatives
GB1338985A (en) N-acyl-biscarbamates and herbicidal preparations containing them
GB1507118A (en) Antibiotic derivatives of 3&#39;,4&#39;-dideoxykanamycin b and the preparation thereof
GB1256723A (en)
GB1363047A (en) Pyrimidine derivative process for its preparation and its use as a medicament
GB1252286A (en)
GB1252975A (en)
GB1382787A (en) Aryl-piperazine derivatives of adenine
GB1314899A (en) Thiosemicarbazones processes for their preparations and compositions incorporating them
IE35783L (en) Molecular complexes
GB1195319A (en) Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines
GB1166793A (en) Substituted Benzamides
GB1221407A (en) 0,2,3,4-tetrahydro-7-substituted-6-sulfamyl-4-quinazolinones, process for preparing the same and pharmaceutical compositions comprising the same
GB1168801A (en) Quinoline Derivatives
IE35640L (en) Diphenyl sulphones.
GB1429390A (en) 2-chloro-4-alkyl- or cycloalkyl-amino-6-methyl-pyrimidines
GB1164058A (en) Novel Sulphanilamides and a process for the manufacture thereof
GB1159748A (en) Thiol-Type Thiamine Thionocarbonates
SE333735B (en)
GB964561A (en) New sulphonamides and process for preparing them
GB1193438A (en) Barbituric Acid Derivatives, preparation thereof and Pharmaceutical Compositions containing them

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees